… Accordingly, we conducted a systemic review and meta-analysis to investigate the
associations of antidiabetic agents with mortality in patients with T2DM who have COVID-19. …

… use of four kinds of hypoglycemic agents (ie, metformin, … and risk of COVID-19 mortality
in patients with type 2 diabetes … various hypoglycemic agents in COVID-19 death risk, and …

… In this systematic review and meta-analysis, we (1) summarized the effects of every single
antidiabetic medication on the mortality of patients with COVID-19 having diabetes and (2) …

… severe forms of COVID-19 that lead to increased mortality. The use of novel antidiabetic
agents dipeptidyl peptidase 4 inhibitors (DPP4i), sodium-glucose co-transporter 2 inhibitors (…

… to review the risk, severity and mortality in COVID-19 and its … , and role of anti-diabetic agents
in patients with diabetes. … nationwide diabetes prevalence of around 11% of type 2 diabetes …

… diabetes and COVID-19 showed that metformin was not … significant reduced mortality risk
in patients with only type 2 diabetes (… mortality risk or poor composite outcomes of COVID-19 …

… literature review, we sought to evaluate the outcomes with non-insulin anti-diabetes agents
in patients of T2DM with COVID-19… study found a 56% relative decrease in all-cause mortality …

… the risk of mortality and ICU admission among COVID-19 … In summary, this systematic review
and meta-analysis … a range of antidiabetic drugs in the management of COVID-19 patients …

… that diabetes is a major risk factor for a severe COVID-19 … of anti-diabetic drugs, their efficacy
in decreasing mortality rates… treatment of COVID-19 patients with type 2 diabetes mellitus (…

… the following: (1) reviews, systematic reviews, correspondences, or in … -analysis on these
seven antidiabetic agents to compare COVID-19 mortality between different antidiabetic agents, …